CXCL12 and synovial sarcoma: In particular, researchers have revealed that the migration of BMMSCs to the site of inflammation is controlled by the stromal cell-derived factor-1 (SDF-1)/CXCR4 axis, which determines the functions of MSCs against SS autoimmunity (119, 206, 208).